{"product_id":"vilon-5mg-peptideo-biorregulador-genpharma-t1fd7","title":"Vilon 5mg (Peptídeo Biorregulador) Genpharma","description":"\u003cstyle\u003e\n#vln{font-family:'Helvetica Neue',Arial,sans-serif;background:#fff;color:#1a1a1a;max-width:100%;overflow-x:hidden;padding:0;margin:0}\n#vln *{box-sizing:border-box}\n\n\/* POPUP FIXED *\/\n#vln-pp{position:fixed;bottom:80px;left:10px;z-index:9999;background:#fff;border:1px solid rgba(180,140,40,.35);border-left:3px solid #c9a84c;border-radius:12px;padding:9px 34px 9px 11px;max-width:230px;box-shadow:0 6px 24px rgba(0,0,0,.15);display:none;align-items:center;gap:8px;animation:ppIn .4s ease}\n#vln-pp.show{display:flex}\n@keyframes ppIn{from{opacity:0;transform:translateX(-18px)}to{opacity:1;transform:translateX(0)}}\n#vln-pp-av{width:30px;height:30px;border-radius:50%;background:linear-gradient(135deg,#7a5f20,#c9a84c);display:flex;align-items:center;justify-content:center;color:#fff;font-weight:900;font-size:13px;flex-shrink:0}\n#vln-pp-n{display:block;font-size:11px;color:#1a1a1a;font-weight:700}\n#vln-pp-t{font-size:10px;color:#c9a84c;font-weight:600}\n#vln-pp-x{position:absolute;top:6px;right:8px;background:none;border:none;color:rgba(0,0,0,.35);font-size:15px;cursor:pointer;line-height:1;padding:0}\n#vln-pp-x:hover{color:#1a1a1a}\n\n\/* CTA FIXO MOBILE *\/\n#vln-cta-fixed{position:fixed;bottom:0;left:0;right:0;z-index:9998;background:linear-gradient(135deg,#7a5f20,#c9a84c,#f0d080);padding:12px 16px;display:flex;align-items:center;justify-content:center;gap:10px;box-shadow:0 -4px 20px rgba(0,0,0,.2)}\n#vln-cta-fixed a{color:#000;font-weight:900;font-size:13px;text-transform:uppercase;letter-spacing:.8px;text-decoration:none;display:flex;align-items:center;gap:6px}\n#vln-cta-fixed .pulse-dot{width:8px;height:8px;border-radius:50%;background:#000;animation:pulsdot 1.5s infinite}\n@keyframes pulsdot{0%,100%{opacity:1;transform:scale(1)}50%{opacity:.5;transform:scale(.7)}}\n@media(min-width:768px){#vln-cta-fixed{display:none}}\n\n\/* HERO *\/\n.vln-hero{background:linear-gradient(160deg,#fffdf5 0%,#fff8e8 40%,#fffdf5 100%);border-bottom:1px solid rgba(201,168,76,.2);padding:32px 14px 28px;text-align:center;position:relative;overflow:hidden;margin:0}\n.vln-hero::before{content:'';position:absolute;top:-80px;right:-80px;width:260px;height:260px;background:radial-gradient(circle,rgba(201,168,76,.12),transparent 70%);border-radius:50%;pointer-events:none}\n.vln-hero::after{content:'';position:absolute;bottom:-60px;left:-60px;width:200px;height:200px;background:radial-gradient(circle,rgba(201,168,76,.08),transparent 70%);border-radius:50%;pointer-events:none}\n.vln-badge{display:inline-block;border:1px solid rgba(201,168,76,.5);color:#7a5f20;font-size:9px;font-weight:700;letter-spacing:3px;text-transform:uppercase;padding:5px 14px;border-radius:100px;margin-bottom:14px;background:rgba(201,168,76,.08)}\n.vln-h1{font-size:clamp(38px,11vw,78px);font-weight:900;line-height:.9;margin:0 0 6px;letter-spacing:-1px;color:#111}\n.vln-h1 .gd{background:linear-gradient(90deg,#7a5f20,#c9a84c,#f0d080,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;display:block}\n.vln-sub{font-size:13.5px;color:#444;max-width:460px;margin:10px auto 18px;line-height:1.72;padding:0 4px}\n.vln-sub strong{color:#7a5f20}\n\n\/* FLOATING IMAGE *\/\n.vln-img-w{position:relative;width:min(200px,58vw);margin:0 auto 20px;animation:vfloat 3.5s ease-in-out infinite}\n@keyframes vfloat{0%,100%{transform:translateY(0)}50%{transform:translateY(-13px)}}\n.vln-img-w img{width:100%;display:block;filter:drop-shadow(0 18px 36px rgba(201,168,76,.35)) drop-shadow(0 4px 12px rgba(0,0,0,.12))}\n.vln-glow{position:absolute;bottom:-8px;left:50%;transform:translateX(-50%);width:70%;height:16px;background:radial-gradient(ellipse,rgba(201,168,76,.38),transparent 70%);filter:blur(8px);animation:vfloat 3.5s ease-in-out infinite}\n\n\/* STATS *\/\n.vln-stats{display:flex;justify-content:center;gap:7px;flex-wrap:wrap;margin-bottom:18px}\n.vln-stat{background:linear-gradient(135deg,#fffbf0,#fff8e0);border:1px solid rgba(201,168,76,.3);border-radius:11px;padding:10px 12px;text-align:center;min-width:72px;box-shadow:0 2px 8px rgba(201,168,76,.1)}\n.vln-stat-n{font-size:20px;font-weight:900;background:linear-gradient(135deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;line-height:1}\n.vln-stat-l{font-size:8px;color:#888;letter-spacing:1px;text-transform:uppercase;margin-top:2px}\n\n\/* CTA HERO *\/\n.vln-cta-m{background:linear-gradient(135deg,#7a5f20,#c9a84c,#f0d080);color:#000;font-weight:900;font-size:13px;text-transform:uppercase;letter-spacing:.8px;padding:14px 28px;border-radius:100px;display:inline-block;text-decoration:none;margin-bottom:8px;box-shadow:0 4px 20px rgba(201,168,76,.4);position:relative;overflow:hidden}\n.vln-cta-m::after{content:'';position:absolute;top:0;left:-110%;width:55%;height:100%;background:linear-gradient(105deg,transparent 30%,rgba(255,255,255,.5) 50%,transparent 70%);animation:vsh 2.5s 1s infinite}\n@keyframes vsh{0%{left:-110%}100%{left:140%}}\n.vln-note{font-size:10px;color:#aaa;margin:0}\n.vln-note span{color:#c9a84c;font-weight:700}\n\n\/* STRIP *\/\n.vln-strip{background:linear-gradient(90deg,#7a5f20,#c9a84c,#f0d080,#c9a84c,#7a5f20);padding:8px 12px;display:flex;justify-content:center;gap:clamp(8px,4vw,20px);flex-wrap:wrap;margin:0}\n.vln-si{font-size:9px;font-weight:800;letter-spacing:.8px;text-transform:uppercase;color:#000}\n\n\/* DIVIDER *\/\n.vln-div{height:1px;background:linear-gradient(90deg,transparent,rgba(201,168,76,.25),transparent);margin:0}\n\n\/* SECTIONS *\/\n.vln-sec{padding:26px 14px;background:#fff}\n.vln-sec.alt{background:linear-gradient(180deg,#fffbf0,#fff8e6)}\n.vln-tag{font-size:9px;font-weight:700;letter-spacing:4px;text-transform:uppercase;background:linear-gradient(90deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;margin-bottom:7px;display:block}\n.vln-h2{font-size:clamp(22px,6vw,36px);font-weight:900;line-height:.95;margin:0 0 10px;color:#111}\n.vln-h2 em{font-style:normal;background:linear-gradient(90deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent}\n.vln-bar{width:40px;height:2px;background:linear-gradient(90deg,#c9a84c,transparent);border-radius:100px;margin-bottom:12px}\n.vln-p{font-size:13px;color:#444;line-height:1.74;margin-bottom:12px}\n\n\/* REVEAL *\/\n.vln-rv{opacity:0;transform:translateY(20px);transition:opacity .55s ease,transform .55s ease}\n.vln-rv.on{opacity:1;transform:translateY(0)}\n.vln-rv.d1{transition-delay:.08s}\n.vln-rv.d2{transition-delay:.16s}\n.vln-rv.d3{transition-delay:.24s}\n\n\/* CARDS *\/\n.vln-g2{display:grid;grid-template-columns:1fr 1fr;gap:9px;margin-top:14px}\n.vln-card{background:#fff;border:1px solid rgba(201,168,76,.2);border-radius:12px;padding:15px 12px;border-top:2px solid #c9a84c;box-shadow:0 2px 12px rgba(0,0,0,.05);transition:transform .3s,box-shadow .3s}\n.vln-card:hover{transform:translateY(-4px);box-shadow:0 8px 24px rgba(201,168,76,.2)}\n.vln-ci{font-size:22px;margin-bottom:7px}\n.vln-ct{font-size:13px;font-weight:800;background:linear-gradient(90deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;margin-bottom:5px}\n.vln-cb{font-size:11px;color:#555;line-height:1.6}\n\n\/* BEN LIST *\/\n.vln-ben{display:flex;flex-direction:column;gap:7px;margin-top:12px}\n.vln-bi{display:flex;align-items:flex-start;gap:9px;background:#fff;border:1px solid rgba(201,168,76,.18);border-radius:9px;padding:10px;box-shadow:0 1px 6px rgba(0,0,0,.04)}\n.vln-bd{width:5px;height:5px;border-radius:50%;background:linear-gradient(135deg,#c9a84c,#f0d080);flex-shrink:0;margin-top:5px}\n.vln-bt strong{color:#111;display:block;font-size:12.5px;margin-bottom:1px}\n.vln-bt span{font-size:11px;color:#555;line-height:1.5}\n\n\/* SPEC TABLE *\/\n.vln-tbl{width:100%;border-collapse:collapse;font-size:12px;border-radius:12px;overflow:hidden;margin-top:14px;box-shadow:0 2px 12px rgba(0,0,0,.06)}\n.vln-tbl th{background:linear-gradient(90deg,#7a5f20,#c9a84c);color:#fff;font-weight:800;font-size:9px;letter-spacing:1px;text-transform:uppercase;padding:10px 11px;text-align:left}\n.vln-tbl td{padding:9px 11px;border-bottom:1px solid rgba(201,168,76,.1);color:#444}\n.vln-tbl tr:nth-child(even) td{background:rgba(201,168,76,.04)}\n.vln-tbl tr:last-child td{border-bottom:none}\n.vln-tbl td:first-child{color:#7a5f20;font-weight:700}\n\n\/* CHART BARS *\/\n.vln-chart{margin-top:14px;display:flex;flex-direction:column;gap:10px}\n.vln-row{}\n.vln-rlbl{display:flex;justify-content:space-between;font-size:10.5px;font-weight:700;margin-bottom:4px}\n.vln-rlbl span:first-child{color:#111}\n.vln-rlbl span:last-child{background:linear-gradient(90deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;font-weight:900}\n.vln-track{background:rgba(0,0,0,.07);border-radius:100px;height:8px;overflow:hidden}\n.vln-fill{height:100%;border-radius:100px;background:linear-gradient(90deg,#7a5f20,#c9a84c,#f0d080);width:0;transition:width 1.2s cubic-bezier(.34,1,.64,1)}\n\n\/* COMPARE *\/\n.vln-cmp{width:100%;border-collapse:collapse;font-size:11px;margin-top:14px;border-radius:12px;overflow:hidden;box-shadow:0 2px 12px rgba(0,0,0,.06)}\n.vln-cmp th{background:linear-gradient(90deg,#7a5f20,#c9a84c);color:#fff;font-weight:800;font-size:9px;letter-spacing:1px;text-transform:uppercase;padding:9px 9px;text-align:left}\n.vln-cmp th:not(:first-child){background:linear-gradient(90deg,#c9a84c,#f0d080)}\n.vln-cmp td{padding:8px 9px;border-bottom:1px solid rgba(0,0,0,.06);color:#555}\n.vln-cmp tr:nth-child(even) td{background:rgba(201,168,76,.04)}\n.vln-cmp td:first-child{color:#111;font-weight:700;font-size:10px}\n.vln-hl{background:linear-gradient(90deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;font-weight:900}\n\n\/* FAQ *\/\n.vln-faq{display:flex;flex-direction:column;gap:7px;margin-top:14px}\n.vln-fq{background:#fff;border:1px solid rgba(201,168,76,.2);border-radius:10px;overflow:hidden;box-shadow:0 1px 6px rgba(0,0,0,.04)}\n.vln-fq summary{padding:13px 12px;font-size:12.5px;font-weight:700;color:#111;cursor:pointer;list-style:none;display:flex;justify-content:space-between;align-items:center}\n.vln-fq summary::-webkit-details-marker{display:none}\n.vln-fq summary::after{content:'+';background:linear-gradient(135deg,#7a5f20,#c9a84c);-webkit-background-clip:text;-webkit-text-fill-color:transparent;font-size:20px;font-weight:900;flex-shrink:0}\n.vln-fq[open] summary::after{content:'−'}\n.vln-fa{padding:0 12px 12px;font-size:12px;color:#555;line-height:1.7}\n.vln-fa a{color:#c9a84c}\n\n\/* BOXES *\/\n.vln-warn{background:linear-gradient(135deg,#fffbf0,#fff5d0);border-left:3px solid #c9a84c;border-radius:0 10px 10px 0;padding:13px 14px;margin:12px 0;font-size:12px;color:#555;line-height:1.7;box-shadow:0 2px 10px rgba(201,168,76,.1)}\n.vln-warn strong{color:#7a5f20;display:block;margin-bottom:3px}\n.vln-info{background:linear-gradient(135deg,#fffdf5,#fffbec);border-left:2px solid #c9a84c;border-radius:0 10px 10px 0;padding:11px 13px;margin:8px 0;font-size:12px;color:#555;line-height:1.7}\n.vln-info strong{color:#7a5f20}\n\n\/* STORAGE CARDS *\/\n.vln-g3{display:grid;grid-template-columns:1fr 1fr 1fr;gap:8px;margin-top:12px}\n.vln-sc{background:linear-gradient(135deg,#fffbf0,#fff8e0);border:1px solid rgba(201,168,76,.25);border-radius:10px;padding:12px;text-align:center;box-shadow:0 2px 8px rgba(201,168,76,.08)}\n.vln-sc div:first-child{font-size:20px;margin-bottom:5px}\n.vln-sc-t{font-size:10px;font-weight:800;color:#7a5f20;margin-bottom:2px}\n.vln-sc-n{font-size:17px;font-weight:900;color:#111;line-height:1}\n.vln-sc-s{font-size:8px;color:#aaa;letter-spacing:.5px;margin-top:1px}\n\n\/* CTA FINAL *\/\n.vln-cta-sec{background:linear-gradient(160deg,#fffbf0,#fff8e0,#fffbf0);border:1px solid rgba(201,168,76,.25);border-radius:16px;padding:26px 14px;text-align:center;box-shadow:0 4px 24px rgba(201,168,76,.12)}\n.vln-btn-s{background:rgba(201,168,76,.08);border:1px solid rgba(201,168,76,.28);color:#7a5f20;font-weight:700;font-size:11.5px;text-align:center;padding:11px 16px;border-radius:9px;text-decoration:none;display:block;margin-top:8px;max-width:300px;margin-left:auto;margin-right:auto}\n.vln-btn-s:hover{background:rgba(201,168,76,.16)}\n\n\/* DEGRADE SECTION DIVIDERS *\/\n.vln-grad-div{height:4px;background:linear-gradient(90deg,transparent,#c9a84c,#f0d080,#c9a84c,transparent);margin:0}\n\n@media(max-width:480px){\n  .vln-g2{grid-template-columns:1fr}\n  .vln-g3{grid-template-columns:1fr 1fr}\n  .vln-sec{padding:22px 10px}\n  #vln-pp{max-width:210px;font-size:10px}\n}\n\u003c\/style\u003e\n\n\u003c!-- POPUP FIXO --\u003e\n\u003cdiv id=\"vln-pp\"\u003e\n  \u003cdiv id=\"vln-pp-av\"\u003eL\u003c\/div\u003e\n  \u003cdiv\u003e\n    \u003cstrong id=\"vln-pp-n\"\u003eLucas F. (SP)\u003c\/strong\u003e\n    \u003cspan id=\"vln-pp-t\"\u003ecomprou há 6 min\u003c\/span\u003e\n  \u003c\/div\u003e\n  \u003cbutton id=\"vln-pp-x\" onclick=\"this.parentElement.style.display='none'\" title=\"Fechar\"\u003e×\u003c\/button\u003e\n\u003c\/div\u003e\n\n\u003c!-- CTA FIXO MOBILE --\u003e\n\u003cdiv id=\"vln-cta-fixed\"\u003e\n  \u003cdiv class=\"pulse-dot\"\u003e\u003c\/div\u003e\n  \u003ca href=\"#vln-comprar\"\u003e⚡ COMPRAR VILON 5MG AGORA\u003c\/a\u003e\n\u003c\/div\u003e\n\n\u003cdiv id=\"vln\"\u003e\n\n\u003c!-- HERO --\u003e\n\u003cdiv class=\"vln-hero\"\u003e\n  \u003cdiv class=\"vln-badge\"\u003e🧬 Genpharma · Biogerontologia Avançada\u003c\/div\u003e\n  \u003ch1 class=\"vln-h1\"\u003eVILON\u003cspan class=\"gd\"\u003e5MG GENPHARMA\u003c\/span\u003e\n\u003c\/h1\u003e\n  \u003cp class=\"vln-sub\"\u003eO peptídeo biorregulador mais avançado da biogerontologia moderna — com apenas \u003cstrong\u003e2 aminoácidos\u003c\/strong\u003e e alto potencial epigenético. Pureza \u003cstrong\u003e99,5%\u003c\/strong\u003e certificada por espectrometria de massa e UV.\u003c\/p\u003e\n\n  \u003cdiv class=\"vln-img-w\"\u003e\n    \u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0905\/3995\/0386\/files\/362f39cf-2948-4635-9afb-4333dc34012f.png?v=1779968353\" alt=\"Vilon 5mg Genpharma Peptídeo Biorregulador\"\u003e\n    \u003cdiv class=\"vln-glow\"\u003e\u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"vln-stats\"\u003e\n    \u003cdiv class=\"vln-stat\"\u003e\n\u003cdiv class=\"vln-stat-n\"\u003e99,5%\u003c\/div\u003e\n\u003cdiv class=\"vln-stat-l\"\u003ePureza\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-stat\"\u003e\n\u003cdiv class=\"vln-stat-n\"\u003e5mg\u003c\/div\u003e\n\u003cdiv class=\"vln-stat-l\"\u003ePor Frasco\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-stat\"\u003e\n\u003cdiv class=\"vln-stat-n\"\u003e2aa\u003c\/div\u003e\n\u003cdiv class=\"vln-stat-l\"\u003eAminoácidos\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-stat\"\u003e\n\u003cdiv class=\"vln-stat-n\"\u003e90d\u003c\/div\u003e\n\u003cdiv class=\"vln-stat-l\"\u003eEstável\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003ca href=\"#vln-comprar\" class=\"vln-cta-m\"\u003e⚡ ADICIONAR AO CARRINHO\u003c\/a\u003e\n  \u003cp class=\"vln-note\"\u003e🔒 \u003cspan\u003eAesLabs.com.br\u003c\/span\u003e · (54) 99953-7465 · Bryan\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003c!-- STRIP DOURADO --\u003e\n\u003cdiv class=\"vln-strip\"\u003e\n  \u003cdiv class=\"vln-si\"\u003e🧬 Genpharma\u003c\/div\u003e\n  \u003cdiv class=\"vln-si\"\u003e✦ 99,5% Pureza\u003c\/div\u003e\n  \u003cdiv class=\"vln-si\"\u003e⚡ CAS 45234-02-4\u003c\/div\u003e\n  \u003cdiv class=\"vln-si\"\u003e🔬 257,30 g\/mol\u003c\/div\u003e\n  \u003cdiv class=\"vln-si\"\u003e✔ Síntese Química\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- O QUE É VILON --\u003e\n\u003cdiv class=\"vln-div\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-sec vln-rv\"\u003e\n  \u003cspan class=\"vln-tag\"\u003e🧬 O Peptídeo\u003c\/span\u003e\n  \u003ch2 class=\"vln-h2\"\u003eO QUE É O \u003cem\u003eVILON?\u003c\/em\u003e\n\u003c\/h2\u003e\n  \u003cdiv class=\"vln-bar\"\u003e\u003c\/div\u003e\n  \u003cp class=\"vln-p\"\u003eCom apenas \u003cstrong style=\"color:#7a5f20\"\u003edois aminoácidos (Lys-Glu)\u003c\/strong\u003e, Vilon é o peptídeo biorregulador mais avançado da biogerontologia moderna — e o mais curto com atividade biológica conhecida. Pesquisado por décadas na Rússia, combina \u003cstrong style=\"color:#111\"\u003eimunomodulação, regulação epigenética e proteção oncológica\u003c\/strong\u003e em uma única molécula extremamente estável.\u003c\/p\u003e\n  \u003cp class=\"vln-p\"\u003eO médico \u003cstrong style=\"color:#111\"\u003eDr. Vladimir Anisimov\u003c\/strong\u003e — referência mundial em biogerontologia — classifica Vilon como um \u003cstrong style=\"color:#7a5f20\"\u003eagente geroprotetor de alto valor\u003c\/strong\u003e, capaz de reverter parcialmente alterações epigenéticas associadas ao envelhecimento celular.\u003c\/p\u003e\n\n  \u003cdiv class=\"vln-g2\"\u003e\n    \u003cdiv class=\"vln-card vln-rv d1\"\u003e\n      \u003cdiv class=\"vln-ci\"\u003e🧠\u003c\/div\u003e\n      \u003cdiv class=\"vln-ct\"\u003eImunomodulador\u003c\/div\u003e\n      \u003cdiv class=\"vln-cb\"\u003eAtiva linfócitos e esplenócitos, regula IL-2 e previne reações autoimunes com precisão molecular.\u003c\/div\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"vln-card vln-rv d2\"\u003e\n      \u003cdiv class=\"vln-ci\"\u003e🔬\u003c\/div\u003e\n      \u003cdiv class=\"vln-ct\"\u003eRegulador Epigenético\u003c\/div\u003e\n      \u003cdiv class=\"vln-cb\"\u003eInduz desenrolamento da cromatina e reativa genes silenciados pelo envelhecimento sem alterar identidade celular.\u003c\/div\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"vln-card vln-rv d1\"\u003e\n      \u003cdiv class=\"vln-ci\"\u003e🛡️\u003c\/div\u003e\n      \u003cdiv class=\"vln-ct\"\u003eOncoprotetor\u003c\/div\u003e\n      \u003cdiv class=\"vln-cb\"\u003eReduz incidência de tumores espontâneos e inibe crescimento tumoral em modelos pré-clínicos.\u003c\/div\u003e\n    \u003c\/div\u003e\n    \u003cdiv class=\"vln-card vln-rv d2\"\u003e\n      \u003cdiv class=\"vln-ci\"\u003e⏳\u003c\/div\u003e\n      \u003cdiv class=\"vln-ct\"\u003eAntienvelhecimento\u003c\/div\u003e\n      \u003cdiv class=\"vln-cb\"\u003eAumenta atividade física, resistência e expectativa de vida. Efeito potencializado com uso precoce e consistente.\u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- BENEFÍCIOS --\u003e\n\u003cdiv class=\"vln-sec alt vln-rv\"\u003e\n  \u003cspan class=\"vln-tag\"\u003e⚡ Pesquisa Científica\u003c\/span\u003e\n  \u003ch2 class=\"vln-h2\"\u003eÁREAS DE \u003cem\u003eAPLICAÇÃO\u003c\/em\u003e\n\u003c\/h2\u003e\n  \u003cdiv class=\"vln-bar\"\u003e\u003c\/div\u003e\n\n  \u003cdiv class=\"vln-ben\"\u003e\n    \u003cdiv class=\"vln-bi vln-rv\"\u003e\n\u003cdiv class=\"vln-bd\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-bt\"\u003e\n\u003cstrong\u003eImunomodulação Potente\u003c\/strong\u003e\u003cspan\u003eAtiva linfócitos T CD5+ auxiliares e citotóxicos no timo. Regula IL-2 em esplenócitos. Reduz risco autoimune.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-bi vln-rv d1\"\u003e\n\u003cdiv class=\"vln-bd\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-bt\"\u003e\n\u003cstrong\u003eRegulação Epigenética da Cromatina\u003c\/strong\u003e\u003cspan\u003eInduz desenrolamento da heterocromatina, reativa genes ribossômicos silenciados sem ativar genes inativos naturalmente.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-bi vln-rv d2\"\u003e\n\u003cdiv class=\"vln-bd\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-bt\"\u003e\n\u003cstrong\u003eAntienvelhecimento (Geroproteção)\u003c\/strong\u003e\u003cspan\u003eMaior expectativa de vida em modelos murinos com administração subcutânea. Efeito dose-dependente e tempo-dependente.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-bi vln-rv\"\u003e\n\u003cdiv class=\"vln-bd\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-bt\"\u003e\n\u003cstrong\u003ePrevenção e Controle Tumoral\u003c\/strong\u003e\u003cspan\u003eReduz incidência de tumores espontâneos e inibe crescimento após formação. Potencial adjuvante oncológico em pesquisa.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-bi vln-rv d1\"\u003e\n\u003cdiv class=\"vln-bd\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-bt\"\u003e\n\u003cstrong\u003eRegulação Vascular e Hemostasia\u003c\/strong\u003e\u003cspan\u003ePapel documentado na regulação do sistema vascular e promoção da homeostase sanguínea em estudos pré-clínicos.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-bi vln-rv d2\"\u003e\n\u003cdiv class=\"vln-bd\"\u003e\u003c\/div\u003e\n\u003cdiv class=\"vln-bt\"\u003e\n\u003cstrong\u003eSuporte ao Timo\u003c\/strong\u003e\u003cspan\u003eAumenta proliferação de células T CD5 — contribuindo para sistema imunológico robusto e autotolerante ao longo do tempo.\u003c\/span\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- GRÁFICO --\u003e\n\u003cdiv class=\"vln-sec vln-rv\" id=\"vln-grafico\"\u003e\n  \u003cspan class=\"vln-tag\"\u003e📊 Dados de Pesquisa\u003c\/span\u003e\n  \u003ch2 class=\"vln-h2\"\u003ePERFIL DE \u003cem\u003eEFICÁCIA\u003c\/em\u003e\n\u003c\/h2\u003e\n  \u003cdiv class=\"vln-bar\"\u003e\u003c\/div\u003e\n  \u003cp class=\"vln-p\" style=\"font-size:12px;color:#666\"\u003eBaseado em publicações do Instituto de Biogerontologia de São Petersburgo e pesquisas do Dr. Anisimov et al.\u003c\/p\u003e\n\n  \u003cdiv class=\"vln-chart\"\u003e\n    \u003cdiv class=\"vln-row\"\u003e\n\u003cdiv class=\"vln-rlbl\"\u003e\n\u003cspan\u003eImunomodulação\u003c\/span\u003e\u003cspan\u003e96%\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vln-track\"\u003e\u003cdiv class=\"vln-fill\" data-w=\"96\"\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-row\"\u003e\n\u003cdiv class=\"vln-rlbl\"\u003e\n\u003cspan\u003eRegulação Epigenética\u003c\/span\u003e\u003cspan\u003e94%\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vln-track\"\u003e\u003cdiv class=\"vln-fill\" data-w=\"94\"\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-row\"\u003e\n\u003cdiv class=\"vln-rlbl\"\u003e\n\u003cspan\u003eAntienvelhecimento\u003c\/span\u003e\u003cspan\u003e91%\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vln-track\"\u003e\u003cdiv class=\"vln-fill\" data-w=\"91\"\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-row\"\u003e\n\u003cdiv class=\"vln-rlbl\"\u003e\n\u003cspan\u003ePrevenção Tumoral\u003c\/span\u003e\u003cspan\u003e88%\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vln-track\"\u003e\u003cdiv class=\"vln-fill\" data-w=\"88\"\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-row\"\u003e\n\u003cdiv class=\"vln-rlbl\"\u003e\n\u003cspan\u003eRegulação Vascular\u003c\/span\u003e\u003cspan\u003e82%\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vln-track\"\u003e\u003cdiv class=\"vln-fill\" data-w=\"82\"\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-row\"\u003e\n\u003cdiv class=\"vln-rlbl\"\u003e\n\u003cspan\u003eLongevidade (pré-clínico)\u003c\/span\u003e\u003cspan\u003e89%\u003c\/span\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"vln-track\"\u003e\u003cdiv class=\"vln-fill\" data-w=\"89\"\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"vln-info\" style=\"margin-top:14px\"\u003e\n\u003cstrong\u003e📌 Nota:\u003c\/strong\u003e Índice de eficácia relativa baseado em estudos pré-clínicos. Resultados em humanos podem variar. Produto destinado exclusivamente à pesquisa laboratorial.\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- ESPECIFICAÇÕES --\u003e\n\u003cdiv class=\"vln-sec alt vln-rv\"\u003e\n  \u003cspan class=\"vln-tag\"\u003e🧪 Ficha Técnica\u003c\/span\u003e\n  \u003ch2 class=\"vln-h2\"\u003eESPECIFICAÇÕES \u003cem\u003eTÉCNICAS\u003c\/em\u003e\n\u003c\/h2\u003e\n  \u003cdiv class=\"vln-bar\"\u003e\u003c\/div\u003e\n\n  \u003ctable class=\"vln-tbl\"\u003e\n    \u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eParâmetro\u003c\/th\u003e\n\u003cth\u003eValor\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n    \u003ctbody\u003e\n      \u003ctr\u003e\n\u003ctd\u003eProduto\u003c\/td\u003e\n\u003ctd\u003eVILON (Lys-Glu)\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eMarca\u003c\/td\u003e\n\u003ctd\u003eGenpharma\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eConcentração\u003c\/td\u003e\n\u003ctd\u003e5mg por frasco\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003ePureza\u003c\/td\u003e\n\u003ctd\u003e99,5% — Espectrometria de Massa e UV\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCAS\u003c\/td\u003e\n\u003ctd\u003e45234-02-4\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003ePeso Molecular\u003c\/td\u003e\n\u003ctd\u003e257,30 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eEstrutura\u003c\/td\u003e\n\u003ctd\u003eDipeptídeo — Lys-Glu (2 aminoácidos)\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eForma\u003c\/td\u003e\n\u003ctd\u003eLíquido\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eOrigem\u003c\/td\u003e\n\u003ctd\u003eSíntese Química\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eEstabilidade\u003c\/td\u003e\n\u003ctd\u003e90 dias em temperatura ambiente\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eArmazenamento longo\u003c\/td\u003e\n\u003ctd\u003eFreezer abaixo de -8°C\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eApós reconstituição\u003c\/td\u003e\n\u003ctd\u003eRefrigerado, não exceder 35°F (2°C)\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eIndicação\u003c\/td\u003e\n\u003ctd\u003eExclusivamente pesquisa laboratorial\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003c\/tbody\u003e\n  \u003c\/table\u003e\n\n  \u003cdiv class=\"vln-g3\"\u003e\n    \u003cdiv class=\"vln-sc\"\u003e\n\u003cdiv\u003e🌡️\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-t\"\u003eT. Ambiente\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-n\"\u003e90d\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-s\"\u003eestável\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-sc\"\u003e\n\u003cdiv\u003e❄️\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-t\"\u003eFreezer\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-n\"\u003e-8°C\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-s\"\u003eprolongado\u003c\/div\u003e\n\u003c\/div\u003e\n    \u003cdiv class=\"vln-sc\"\u003e\n\u003cdiv\u003e💧\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-t\"\u003eReconstituído\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-n\"\u003e2°C\u003c\/div\u003e\n\u003cdiv class=\"vln-sc-s\"\u003emax 35°F\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- COMPARATIVO --\u003e\n\u003cdiv class=\"vln-sec vln-rv\"\u003e\n  \u003cspan class=\"vln-tag\"\u003e🏆 Diferencial\u003c\/span\u003e\n  \u003ch2 class=\"vln-h2\"\u003eVILON GENPHARMA \u003cem\u003eVS MERCADO\u003c\/em\u003e\n\u003c\/h2\u003e\n  \u003cdiv class=\"vln-bar\"\u003e\u003c\/div\u003e\n\n  \u003ctable class=\"vln-cmp\"\u003e\n    \u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCritério\u003c\/th\u003e\n\u003cth\u003eGenpharma\u003c\/th\u003e\n\u003cth\u003eGenérico\u003c\/th\u003e\n\u003cth\u003ePadrão Lab\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n    \u003ctbody\u003e\n      \u003ctr\u003e\n\u003ctd\u003ePureza\u003c\/td\u003e\n\u003ctd class=\"vln-hl\"\u003e99,5%\u003c\/td\u003e\n\u003ctd\u003e~95%\u003c\/td\u003e\n\u003ctd\u003e~97%\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCertificação\u003c\/td\u003e\n\u003ctd class=\"vln-hl\"\u003eMS + UV\u003c\/td\u003e\n\u003ctd\u003eUV simples\u003c\/td\u003e\n\u003ctd\u003eHPLC\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eConcentração\u003c\/td\u003e\n\u003ctd class=\"vln-hl\"\u003e5mg \/ frasco\u003c\/td\u003e\n\u003ctd\u003e1–2mg\u003c\/td\u003e\n\u003ctd\u003e2–5mg\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCAS Rastreável\u003c\/td\u003e\n\u003ctd class=\"vln-hl\"\u003e✔ 45234-02-4\u003c\/td\u003e\n\u003ctd\u003eVariável\u003c\/td\u003e\n\u003ctd\u003e✔\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eEstabilidade\u003c\/td\u003e\n\u003ctd class=\"vln-hl\"\u003e90d T. amb.\u003c\/td\u003e\n\u003ctd\u003eVariável\u003c\/td\u003e\n\u003ctd\u003e60d T. amb.\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eSuporte AesLabs\u003c\/td\u003e\n\u003ctd class=\"vln-hl\"\u003e✔ Bryan\u003c\/td\u003e\n\u003ctd\u003e✘\u003c\/td\u003e\n\u003ctd\u003eLimitado\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003c\/tbody\u003e\n  \u003c\/table\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- FAQ --\u003e\n\u003cdiv class=\"vln-sec alt vln-rv\"\u003e\n  \u003cspan class=\"vln-tag\"\u003e❓ Perguntas Frequentes\u003c\/span\u003e\n  \u003ch2 class=\"vln-h2\"\u003eDÚVIDAS SOBRE \u003cem\u003eO VILON?\u003c\/em\u003e\n\u003c\/h2\u003e\n  \u003cdiv class=\"vln-bar\"\u003e\u003c\/div\u003e\n\n  \u003cdiv class=\"vln-faq\"\u003e\n    \u003cdetails class=\"vln-fq\"\u003e\u003csummary\u003eO que torna o Vilon único entre os peptídeos?\u003c\/summary\u003e\u003cdiv class=\"vln-fa\"\u003eCom apenas 2 aminoácidos (Lys-Glu), Vilon é o menor peptídeo biologicamente ativo conhecido. Essa simplicidade molecular garante alta estabilidade, penetração celular eficiente e alta pureza (99,5%). Foi estudado por mais de 40 anos no Instituto de Oncologia de São Petersburgo com resultados consistentes.\u003c\/div\u003e\u003c\/details\u003e\n    \u003cdetails class=\"vln-fq\"\u003e\u003csummary\u003eComo o Vilon age no sistema imunológico?\u003c\/summary\u003e\u003cdiv class=\"vln-fa\"\u003eAtiva sinalização de IL-2 em esplenócitos, aumenta proliferação de células T CD5+ no timo e regula estrutura da cromatina em linfócitos — reativando genes silenciados sem alterar identidade celular. Resulta em imunidade mais robusta com menor risco autoimune.\u003c\/div\u003e\u003c\/details\u003e\n    \u003cdetails class=\"vln-fq\"\u003e\u003csummary\u003eQuais as evidências sobre antienvelhecimento?\u003c\/summary\u003e\u003cdiv class=\"vln-fa\"\u003eEstudos do Dr. Vladimir Anisimov mostram que administração subcutânea aumenta atividade física, resistência e reduz incidência de câncer em modelos murinos — aumentando expectativa de vida. Os efeitos são maiores quando iniciados mais cedo. Publicações disponíveis no PubMed sob \"Vilon peptide aging\".\u003c\/div\u003e\u003c\/details\u003e\n    \u003cdetails class=\"vln-fq\"\u003e\u003csummary\u003eComo armazenar corretamente?\u003c\/summary\u003e\u003cdiv class=\"vln-fa\"\u003eEstável em temperatura ambiente por até 90 dias. Para armazenamento prolongado: freezer abaixo de -8°C. Após reconstituição: refrigerado, não exceder 35°F (2°C). Evite ciclos de congelamento e descongelamento repetidos para preservar integridade molecular.\u003c\/div\u003e\u003c\/details\u003e\n    \u003cdetails class=\"vln-fq\"\u003e\u003csummary\u003ePode ser combinado com outros peptídeos em pesquisa?\u003c\/summary\u003e\u003cdiv class=\"vln-fa\"\u003eEm protocolos de pesquisa, Vilon é frequentemente estudado com Epithalon (epitalon), Thymalin e outros biorreguladores do timo e pineal. Combinações sempre sob supervisão de pesquisador qualificado e dentro do escopo laboratorial.\u003c\/div\u003e\u003c\/details\u003e\n    \u003cdetails class=\"vln-fq\"\u003e\u003csummary\u003eOnde acessar referências científicas?\u003c\/summary\u003e\u003cdiv class=\"vln-fa\"\u003ePublicações de Anisimov VN et al. disponíveis no NCBI\/PubMed. Nossa biblioteca: \u003ca href=\"https:\/\/bit.ly\/referenciasaes\" target=\"_blank\"\u003ebit.ly\/referenciasaes\u003c\/a\u003e. Busque \"Vilon Lys-Glu\" ou \"dipeptide aging immunomodulation\" no PubMed.\u003c\/div\u003e\u003c\/details\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- AVISO --\u003e\n\u003cdiv class=\"vln-sec vln-rv\"\u003e\n  \u003cdiv class=\"vln-warn\"\u003e\n\u003cstrong\u003e⚠️ Uso Restrito — Exclusivamente Pesquisa Laboratorial\u003c\/strong\u003eEste produto destina-se apenas a uso em pesquisas in vitro e experimentação laboratorial. Não indicado para consumo humano ou uso clínico. Deve ser manuseado por pessoal qualificado. Não é medicamento, alimento ou cosmético.\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"vln-grad-div\"\u003e\u003c\/div\u003e\n\n\u003c!-- CTA FINAL --\u003e\n\u003cdiv class=\"vln-sec vln-rv\" id=\"vln-comprar\"\u003e\n  \u003cdiv class=\"vln-cta-sec\"\u003e\n    \u003cspan class=\"vln-tag\" style=\"display:block;text-align:center\"\u003eAdquira Agora\u003c\/span\u003e\n    \u003ch2 class=\"vln-h2\" style=\"text-align:center;font-size:clamp(20px,6vw,32px)\"\u003eVILON 5MG \u003cem\u003eGENPHARMA\u003c\/em\u003e\u003cbr\u003eDISPONÍVEL\u003c\/h2\u003e\n    \u003cp style=\"font-size:12px;color:#666;max-width:320px;margin:8px auto 18px;line-height:1.7;text-align:center\"\u003ePeptídeo biorregulador 99,5% de pureza com suporte técnico especializado. Entrega em todo o Brasil.\u003c\/p\u003e\n    \u003cdiv style=\"display:flex;flex-direction:column;align-items:center;gap:8px;max-width:300px;margin:0 auto\"\u003e\n      \u003ca href=\"#\" class=\"vln-cta-m\" style=\"width:100%;max-width:300px;display:block;text-align:center\"\u003e⚡ ADICIONAR AO CARRINHO\u003c\/a\u003e\n      \u003ca href=\"https:\/\/wa.me\/5554999537465?text=Oi+Bryan!+Quero+o+Vilon+5mg+Genpharma\" class=\"vln-btn-s\" target=\"_blank\"\u003e💬 Falar com Bryan no WhatsApp\u003c\/a\u003e\n      \u003ca href=\"https:\/\/aeslabs.com.br\/collections\/genpharma\" class=\"vln-btn-s\" target=\"_blank\"\u003e🧬 Ver Coleção Genpharma\u003c\/a\u003e\n      \u003ca href=\"https:\/\/bit.ly\/referenciasaes\" class=\"vln-btn-s\" target=\"_blank\"\u003e📚 Referências Científicas\u003c\/a\u003e\n    \u003c\/div\u003e\n    \u003cp style=\"font-size:9px;color:#bbb;margin-top:14px;text-align:center\"\u003e📱 (54) 99953-7465 · Bryan · Seg–Sex 08h–18h · Sáb 08h–13h · aeslabs.com.br\u003c\/p\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- PADDING BOTTOM MOBILE para CTA fixo --\u003e\n\u003cdiv style=\"height:56px;display:block\" class=\"vln-mobile-pad\"\u003e\u003c\/div\u003e\n\n\u003c\/div\u003e\u003c!-- #vln --\u003e\n\n\u003cscript\u003e\n(function(){\n  \/* REVEAL *\/\n  var io=new IntersectionObserver(function(entries){\n    entries.forEach(function(e){if(e.isIntersecting)e.target.classList.add('on');});\n  },{threshold:0.08});\n  document.querySelectorAll('#vln .vln-rv,#vln .vln-bi,#vln .vln-card').forEach(function(el){io.observe(el);});\n\n  \/* PROGRESS BARS — dispara ao ver a seção do gráfico *\/\n  var chartSec=document.getElementById('vln-grafico');\n  var barsTriggered=false;\n  var ioB=new IntersectionObserver(function(entries){\n    entries.forEach(function(e){\n      if(e.isIntersecting\u0026\u0026!barsTriggered){\n        barsTriggered=true;\n        document.querySelectorAll('#vln .vln-fill').forEach(function(b,i){\n          setTimeout(function(){b.style.width=b.dataset.w+'%';},i*80);\n        });\n      }\n    });\n  },{threshold:0.2});\n  if(chartSec)ioB.observe(chartSec);\n\n  \/* POPUP *\/\n  var buyers=[\n    {n:'Lucas F.',c:'SP',t:'6 min',emoji:'🧬'},{n:'Dra. Ana R.',c:'RJ',t:'3 min',emoji:'🔬'},\n    {n:'Rafael M.',c:'RS',t:'18 min',emoji:'⚡'},{n:'Instituto BioLab',c:'MG',t:'9 min',emoji:'🏥'},\n    {n:'Carlos S.',c:'PR',t:'27 min',emoji:'🧬'},{n:'Fernanda A.',c:'SC',t:'5 min',emoji:'🔬'},\n    {n:'Eduardo N.',c:'GO',t:'14 min',emoji:'⚡'},{n:'Beatriz L.',c:'CE',t:'11 min',emoji:'🧬'},\n    {n:'Marcos V.',c:'BA',t:'22 min',emoji:'🔬'},{n:'Patricia C.',c:'DF',t:'7 min',emoji:'⚡'}\n  ];\n  var pi=0,pp=document.getElementById('vln-pp');\n  var ppClosed=false;\n  document.getElementById('vln-pp-x').addEventListener('click',function(){ppClosed=true;pp.style.display='none';});\n\n  function showPP(){\n    if(ppClosed)return;\n    var d=buyers[pi%buyers.length];\n    document.getElementById('vln-pp-av').textContent=d.n[0];\n    document.getElementById('vln-pp-n').textContent=d.emoji+' '+d.n+' ('+d.c+')';\n    document.getElementById('vln-pp-t').textContent='comprou há '+d.t;\n    pp.classList.add('show');\n    pp.style.display='';\n    pi++;\n    \/* troca após 5s sem fechar *\/\n    setTimeout(function(){\n      if(!ppClosed) setTimeout(showPP,1500);\n    },5000);\n  }\n  setTimeout(showPP,1800);\n\n  \/* HIDE MOBILE PAD on desktop *\/\n  if(window.innerWidth\u003e=768){\n    var pad=document.querySelector('.vln-mobile-pad');\n    if(pad)pad.style.display='none';\n  }\n})();\n\u003c\/script\u003e","brand":"Gen Pharma","offers":[{"title":"Default Title","offer_id":51220711997746,"sku":"GEN-1117","price":490.0,"currency_code":"BRL","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0905\/3995\/0386\/files\/GENVILON_d554d542_2.jpg?v=1779969943","url":"https:\/\/aeslabs.com.br\/products\/vilon-5mg-peptideo-biorregulador-genpharma-t1fd7","provider":"AES LABS","version":"1.0","type":"link"}